Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
Open | $3.010 |
Close | $3.020 |
Volume / Avg. | 78.687K / 302.706K |
Day Range | 2.900 - 3.130 |
52 Wk Range | 2.670 - 9.250 |
Market Cap | $83.197M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 5.68% |
Days to Cover | 2.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Other companies in Reviva Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX), Marinus Pharma (NASDAQ:MRNS) and Anebulo Pharmaceuticals (NASDAQ:ANEB).
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by HC Wainwright & Co. on Monday, April 22, 2024. The analyst firm set a price target for 20.00 expecting RVPH to rise to within 12 months (a possible 571.14% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $2.98 last updated Today at April 24, 2024 at 4:42 PM EDT.
There are no upcoming dividends for Reviva Pharmaceuticals.
Reviva Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Reviva Pharmaceuticals.
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.